Drug Interactions between Pulmicort Respules and ziconotide
This report displays the potential drug interactions for the following 2 drugs:
- Pulmicort Respules (budesonide)
Interactions between your drugs
No interactions were found between Pulmicort Respules and ziconotide. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Pulmicort respules is in the drug class inhaled corticosteroids.
- Pulmicort respules is used to treat Asthma, Maintenance.
- Ziconotide is in the drug class miscellaneous analgesics.
- Ziconotide is used to treat the following conditions:
Drug and food interactions
Applies to: Pulmicort Respules (budesonide)
You should avoid the regular consumption of large amounts of grapefruits and grapefruit juice while taking budesonide. Grapefruit can raise the levels of budesonide in your body and lead to increased side effects. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
Applies to: ziconotide
Alcohol can increase the nervous system side effects of ziconotide such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with ziconotide. Do not use more than the recommended dose of ziconotide, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.